ORBUS PHARMA INC has a total of 16 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and macromolecular chemistry and polymers are NEUROPHYXIA B V, SHIMODA BIOTECH PTY LTD and BEIJING INNO MEDICINE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | United States | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Laxminarayan Joshi | 8 |
#2 | Joshi Laxminarayan | 7 |
#3 | Lefler Robert Scott | 3 |
#4 | Kotzagiorgis Evangelos | 1 |
#5 | Karavas Evangelos | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007048233A1 | Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist | |
US2009247603A1 | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor | |
WO2007016757A1 | Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor | |
US2006229277A1 | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor | |
EP1342470A1 | Fast release cefuroxime axetil compositions |